Spero Therapeutics (SPRO) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Spero Therapeutics (SPRO) over the last 9 years, with Q4 2024 value amounting to $3.6 million.
- Spero Therapeutics' Accumulated Depreciation & Amortization rose 5.53% to $3.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.6 million, marking a year-over-year increase of 5.53%. This contributed to the annual value of $3.6 million for FY2024, which is 5.53% up from last year.
- As of Q4 2024, Spero Therapeutics' Accumulated Depreciation & Amortization stood at $3.6 million, which was up 5.53% from $3.6 million recorded in Q4 2023.
- Spero Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $3.6 million during Q4 2024, with a 5-year trough of $2.3 million in Q4 2020.
- Its 5-year average for Accumulated Depreciation & Amortization is $3.1 million, with a median of $3.3 million in 2022.
- Per our database at Business Quant, Spero Therapeutics' Accumulated Depreciation & Amortization surged by 5023.1% in 2020 and then rose by 5.53% in 2024.
- Quarter analysis of 5 years shows Spero Therapeutics' Accumulated Depreciation & Amortization stood at $2.3 million in 2020, then rose by 26.54% to $2.9 million in 2021, then rose by 12.92% to $3.3 million in 2022, then increased by 11.25% to $3.6 million in 2023, then rose by 0.06% to $3.6 million in 2024.
- Its Accumulated Depreciation & Amortization was $3.6 million in Q4 2024, compared to $3.6 million in Q4 2023 and $3.3 million in Q4 2022.